STEAP1 and cancer: Likewise, several in vitro and in vivo studies revealed that STEAP1-derived peptides are immunogenic and hence suitable for recognition by cytotoxic T lymphocytes [13,14], suggesting their potential use in the development of anti-cancer vaccines.